Visual hallucinations after resection of cerebral metastases: two patients with complex phantom images
ConclusionThis case serves to heighten awareness in the radiooncology practitioner of the occurrence of visual release hallucinations (Charles Bonnet syndrome) related to multidisciplinary treatment of brain metastases. (Source: Strahlentherapie und Onkologie)
Source: Strahlentherapie und Onkologie - March 7, 2024 Category: Cancer & Oncology Source Type: research
Stereotactic body radiotherapy (SBRT) re-irradiation for local failures following radical prostatectomy and post-operative radiotherapy
ConclusionsManageable toxicity profile and satisfactory biochemical response suggest that SBRT in patients with local recurrence following RP and postoperative RT might be a salvage option for selected patients. (Source: Strahlentherapie und Onkologie)
Source: Strahlentherapie und Onkologie - March 1, 2024 Category: Cancer & Oncology Source Type: research
Comprehensive geriatric assessment predicts radiation-induced acute toxicity in prostate cancer patients
ConclusionGeriatric conditions seem to be predictive of the development of high-grade radiation-induced toxicity in prostate cancer patients treated with definitive radiotherapy. (Source: Strahlentherapie und Onkologie)
Source: Strahlentherapie und Onkologie - March 1, 2024 Category: Cancer & Oncology Source Type: research
Noninvasive inter- and intrafractional motion control in ultrahypofractionated radiation therapy of prostate cancer using RayPilot HypoCath ™—a substitute for gold fiducial-based IGRT?
Conclusionthe HypoCath system allows highly accurate and robust intrafractional motion monitoring. In conjunction with cone beam CT (CBCT) for initial patient setup, it could be used as a standalone image-guided radiation therapy (IGRT) system. (Source: Strahlentherapie und Onkologie)
Source: Strahlentherapie und Onkologie - March 1, 2024 Category: Cancer & Oncology Source Type: research
Stereotactic body radiotherapy (SIB-VMAT technique) to dominant intraprostatic lesion (DIL) for localized prostate cancer: a dose-escalation trial (DESTROY-4).
ConclusionThis trial confirms the feasibility and safety of a total SIB-VMAT dose of 35 Gy on the whole gland and 50 Gy on DIL in 5 fractions daily administered in a well-selected low- and intermediate-risk prostate carcinoma population. A phase II study is ongoing to confirm the tolerability of the schedule and assess the efficacy. (Source: Strahlentherapie und Onkologie)
Source: Strahlentherapie und Onkologie - March 1, 2024 Category: Cancer & Oncology Source Type: research
Prostate cancer and elective nodal radiation therapy for cN0 and pN0 —a never ending story?
AbstractFor prostate cancer, the role of elective nodal irradiation (ENI) for cN0 or pN0 patients has been under discussion for years. Considering the recent publications of randomized controlled trials, the prostate cancer expert panel of the German Society of Radiation Oncology (DEGRO) aimed to discuss and summarize the current literature. Modern trials have been recently published for both treatment-na ïve patients (POP-RT trial) and patients after surgery (SPPORT trial). Although there are more reliable data to date, we identified several limitations currently complicating the definitions of general recommendations. F...
Source: Strahlentherapie und Onkologie - March 1, 2024 Category: Cancer & Oncology Source Type: research
Whole-pelvic irradiation with boost to involved nodes and prostate in node-positive prostate cancer —long-term data from the prospective PLATIN-2 trial
ConclusionDefinitive radiation to the lymphatic drainage with SIB to the involved nodes and prostate is a safe and effective treatment approach for patients with treatment-naïve, node-positive prostate cancer with excellent infield tumor control rates and tolerable toxicity. Location rather than number of involved nodes is a major risk factor for progression. (Source: Strahlentherapie und Onkologie)
Source: Strahlentherapie und Onkologie - March 1, 2024 Category: Cancer & Oncology Source Type: research
Die MIRAGE-Studie (MR-Linac-basierte K örperstereotaxie bei Prostatakarzinomen) – Precision at its best?
(Source: Strahlentherapie und Onkologie)
Source: Strahlentherapie und Onkologie - March 1, 2024 Category: Cancer & Oncology Source Type: research
F ünfzehn-Jahres Ergebnisse nach Monitoring, Operation oder Strahlentherapie aufgrund eines Prostatakarzinoms
(Source: Strahlentherapie und Onkologie)
Source: Strahlentherapie und Onkologie - March 1, 2024 Category: Cancer & Oncology Source Type: research
Prophylaktische Strahlentherapie bei asymptomatischen Hochrisiko-Knochenmetastasen
(Source: Strahlentherapie und Onkologie)
Source: Strahlentherapie und Onkologie - March 1, 2024 Category: Cancer & Oncology Source Type: research
Nintedanib zur Therapie der radiogenen Pneumonitis
(Source: Strahlentherapie und Onkologie)
Source: Strahlentherapie und Onkologie - February 29, 2024 Category: Cancer & Oncology Source Type: research
Cost –benefit ratio of modern medical education using micro-costing: a model calculation using the example of an innovative breast brachytherapy workshop
ConclusionThe hands-on brachytherapy workshop proved to be a valuable and approximately cost-effective educational program, leading to a significant enhancement in the knowledge and skills of the participants. Without the support of industrial sponsorship, the costs would have been unattainable. (Source: Strahlentherapie und Onkologie)
Source: Strahlentherapie und Onkologie - February 28, 2024 Category: Cancer & Oncology Source Type: research
Longer time to testosterone recovery impacts favorably on outcomes for prostate cancer following androgen deprivation and radiotherapy
ConclusionOur data show an association between longer TTR and bRFS values among PCa patients treated with ADT. (Source: Strahlentherapie und Onkologie)
Source: Strahlentherapie und Onkologie - February 28, 2024 Category: Cancer & Oncology Source Type: research
Cost –benefit ratio of modern medical education using micro-costing: a model calculation using the example of an innovative breast brachytherapy workshop
ConclusionThe hands-on brachytherapy workshop proved to be a valuable and approximately cost-effective educational program, leading to a significant enhancement in the knowledge and skills of the participants. Without the support of industrial sponsorship, the costs would have been unattainable. (Source: Strahlentherapie und Onkologie)
Source: Strahlentherapie und Onkologie - February 28, 2024 Category: Cancer & Oncology Source Type: research
